Skip to Content

APO F43 (Fenofibrate (Micronized) 43 mg)

Pill with imprint APO F43 is Green & White, Capsule-shape and has been identified as Fenofibrate (Micronized) 43 mg. It is supplied by Apotex Corp..

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 43 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO F43

Fenofibrate (micronized) 43 mg APO F43

Fenofibrate (Micronized)

Imprint
APO F43
Strength
43 mg
Color
Green & White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Apotex Corp.
National Drug Code (NDC)
60505-3120

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.